4-YEAR STUDY OF INTERMITTENT CYCLIC ETIDRONATE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS

被引：0
作者：
LOELIGER, EA
机构：
来源：
AMERICAN JOURNAL OF MEDICINE | 1995年 / 99卷 / 02期
关键词：
D O I：
10.1016/S0002-9343(99)80150-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：225 / 225
页数：1
相关论文
共 50 条
[31]   TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS WITH PHOSPHATE AND INTERMITTENT CALCITONIN [J].
KUNTZ, D ;
MARIE, P ;
BERTHEL, M ;
CAULIN, F .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1986, 6 (02) :157-162
[32]   Alendronate increases bone mineral density at spine and hip in women with postmenopausal osteoporosis who fail to respond to intermittent cyclic etidronate. [J].
Watts, NB ;
Becker, P .
JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 :P279-P279
[33]   Comparison of the efficiency and safety of cyclic etidronate versus sodium fluoride in postmenopausal osteoporosis. [J].
Guanabens, N ;
Farrerons, J ;
PerezEdo, L ;
Monegal, A ;
Renau, A ;
Roca, M ;
Pavesi, M ;
Carbonell, J .
JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 :M653-M653
[34]   EFFECT OF INTERMITTENT CYCLICAL ETIDRONATE THERAPY ON BONE MASS AND FRACTURE RATE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS [J].
STORM, T ;
THAMSBORG, G ;
STEINICHE, T ;
GENANT, HK ;
SORENSEN, OH .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (18) :1265-1271
[35]   Beneficial effect on bone density in male osteoporosis of postmenopausal osteoporosis treatment (fluoride, etidronate, and calcitriol) [J].
Laroche, M ;
Andrieu, V ;
Constantin, A ;
Mazieres, B .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1998, 16 (06) :760-760
[36]   Cyclical etidronate in the treatment of postmenopausal osteoporosis: Efficacy and safety after seven years of treatment [J].
Miller, PD ;
Watts, NB ;
Licata, AA ;
Harris, ST ;
Genant, HK ;
Wasnich, RD ;
Ross, PD ;
Jackson, RD ;
Hoseyni, MS ;
Schoenfeld, SL ;
Valent, DJ ;
Chesnut, CH .
AMERICAN JOURNAL OF MEDICINE, 1997, 103 (06) :468-476
[37]   Efficacy of etidronate and sequential monofluorophosphate in severe postmenopausal osteoporosis: a pilot study [J].
J. D. Ringe ;
A. Dorst ;
H. Faber ;
C. Kipshoven ;
L. C. Rovati ;
I. Setnikar .
Rheumatology International, 2005, 25 :296-300
[38]   Efficacy of etidronate and sequential monofluorophosphate in severe postmenopausal osteoporosis: a pilot study [J].
Ringe, J ;
Dorst, A ;
Faber, H ;
Kipshoven, C ;
Rovati, L ;
Setnikar, I .
RHEUMATOLOGY INTERNATIONAL, 2005, 25 (04) :296-300
[39]   BONE HISTOMORPHOMETRIC CHANGES AFTER CYCLIC THERAPY WITH PHOSPHATE AND ETIDRONATE DISODIUM IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS [J].
OTT, SM ;
WOODSON, GC ;
HUFFER, WE ;
MILLER, PD ;
WATTS, NB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (04) :968-972
[40]   An efficacious method of treating postmenopausal osteoporosis: Combined therapy of estrogen and bisphosphonate: 4-year randomized controlled study. [J].
Wimalawansa, SJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 :P268-P268
12345